IRIS Accounts Production v23.3.1.45 07215572 Board of Directors 1.5.22 30.4.23 30.4.23 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh072155722022-04-30072155722023-04-30072155722022-05-012023-04-30072155722021-04-30072155722021-05-012022-04-30072155722022-04-3007215572ns10:Originalns15:EnglandWales2022-05-012023-04-3007215572ns14:PoundSterlingns10:Original2022-05-012023-04-3007215572ns10:Originalns10:Director12022-05-012023-04-3007215572ns10:Original2022-05-012023-04-3007215572ns10:Original2023-04-3007215572ns10:Originalns10:PrivateLimitedCompanyLtd2022-05-012023-04-3007215572ns10:Originalns10:SmallEntities2022-05-012023-04-3007215572ns10:Originalns10:AuditExempt-NoAccountantsReport2022-05-012023-04-3007215572ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-05-012023-04-3007215572ns10:SmallCompaniesRegimeForAccountsns10:Original2022-05-012023-04-3007215572ns10:Originalns10:FullAccounts2022-05-012023-04-3007215572ns10:Originalns10:OrdinaryShareClass12022-05-012023-04-3007215572ns10:Originalns10:Director22022-05-012023-04-3007215572ns10:Originalns10:RegisteredOffice2022-05-012023-04-3007215572ns10:Original2022-04-3007215572ns10:Originalns5:CurrentFinancialInstruments2023-04-3007215572ns10:Originalns5:CurrentFinancialInstruments2022-04-3007215572ns5:ShareCapitalns10:Original2023-04-3007215572ns5:ShareCapitalns10:Original2022-04-3007215572ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-04-3007215572ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-04-3007215572ns10:Originalns5:PlantMachinery2022-05-012023-04-3007215572ns10:Originalns5:ComputerEquipment2022-05-012023-04-3007215572ns10:Original2021-05-012022-04-3007215572ns10:Originalns5:PlantMachinery2022-04-3007215572ns10:Originalns5:PlantMachinery2023-04-3007215572ns10:Originalns5:PlantMachinery2022-04-3007215572ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-04-3007215572ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-04-3007215572ns10:Originalns10:OrdinaryShareClass12023-04-30
REGISTERED NUMBER: 07215572 (England and Wales)















MILLFIELD MEDICAL LIMITED

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 APRIL 2023






MILLFIELD MEDICAL LIMITED (REGISTERED NUMBER: 07215572)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


MILLFIELD MEDICAL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 APRIL 2023







DIRECTORS: Dr M Davis
Mrs J Davis





REGISTERED OFFICE: Millfield House
Gayton
Stafford
Staffordshire
ST18 0HQ





REGISTERED NUMBER: 07215572 (England and Wales)

MILLFIELD MEDICAL LIMITED (REGISTERED NUMBER: 07215572)

BALANCE SHEET
30 APRIL 2023

2023 2022
Notes £    £   
FIXED ASSETS
Tangible assets 4 1,334 928

CURRENT ASSETS
Debtors 5 1,915 14,168
Cash at bank 143,244 132,514
145,159 146,682
CREDITORS
Amounts falling due within one year 6 (9,976 ) (20,924 )
NET CURRENT ASSETS 135,183 125,758
TOTAL ASSETS LESS CURRENT LIABILITIES 136,517 126,686

CAPITAL AND RESERVES
Called up share capital 7 100 100
Retained earnings 136,417 126,586
SHAREHOLDERS' FUNDS 136,517 126,686

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 17 January 2024 and were signed on its behalf by:



Dr M Davis - Director


MILLFIELD MEDICAL LIMITED (REGISTERED NUMBER: 07215572)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2023


1. STATUTORY INFORMATION

Millfield Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements are presented in sterling which is the functional currency of the company and rounded to the nearest £.

The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated.

Turnover
Turnover is measured at the fair value of the consideration received or receivable net of VAT and trade discounts. The policies adopted for the recognition of turnover are as follows:

When the outcome of a transaction can be estimated reliably, turnover from medical services is recognised by reference to the stage of completion at the balance sheet date.

Where the outcome cannot be measured reliably, turnover is recognised only to the extent of the expenses recognised that are recoverable.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance
Computer equipment - 25% on reducing balance

Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended.

Tax
Current tax represents the amount of tax payable or receivable in respect of the taxable profit (or loss) for the current or past reporting periods. It is measured at the amount expected to be paid or recovered using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax represents the future tax consequences of transactions and events recognised in the financial statements of current and previous periods. It is recognised in respect of all timing differences, with certain exceptions. Timing differences are differences between taxable profits and total comprehensive income as stated in the financial statements that arise from the inclusion of income and expense in tax assessments in periods different from those in which they are recognised in the financial statements.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date that are expected to apply to the reversal of timing differences.

MILLFIELD MEDICAL LIMITED (REGISTERED NUMBER: 07215572)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2023


2. ACCOUNTING POLICIES - continued

Debtors and creditors receivable/payable within one year
Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 May 2022 2,897
Additions 850
At 30 April 2023 3,747
DEPRECIATION
At 1 May 2022 1,969
Charge for year 444
At 30 April 2023 2,413
NET BOOK VALUE
At 30 April 2023 1,334
At 30 April 2022 928

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 1,718 13,973
Prepayments and accrued income 197 195
1,915 14,168

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Tax 3,329 9,681
Directors' current accounts 5,513 10,163
Accrued expenses 1,134 1,080
9,976 20,924

MILLFIELD MEDICAL LIMITED (REGISTERED NUMBER: 07215572)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2023


7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
100 Ordinary £1 100 100